Flu & Viruses
-
COVID-19 in Africa ‘vastly underestimated’
The number of COVID-19 deaths in Africa could be far greater than those reported, a study published today warns. Read more
-
Challenge testing will trial COVID inoculation
The UK is to run the world’s first challenge testing for COVID-19 vaccine development in a bid to speed up the response to rapidly developing mutations, it has been announced. Read more
-
Neanderthal descendants get COVID protection
Descendants of Neanderthals may enjoy some genetic protection against the COVID-19 virus, according to a new scientific study. Read more
-
COVID phase one trials get UK bulk test approach
The UK is to adapt an innovative clinical trial procedure in a bid to fast-track untested new drugs for COVID-19 treatment, it has been announced. Read more
-
Oxford vaccine prevents hospital admission – WHO
The Oxford University COVID-19 vaccine has gained key backing from international experts after a series of controversies. Read more
-
South African variant evades vaccine
The Oxford adenoviral vaccine has had little success in preventing infection with the South African mutation of COVID-19, it has been announced raising new concerns about the virus’s ability to mutate to avoid vaccines. Read more
-
Doctors warn of COVID-19 re-infection risk
It may be possible to have two separate episodes of serious COVID-19 infection because of waning immunity, doctors have warned. Read more
-
Gout drug aids COVID-19 patients
A cheap drug used to treat gout helps to reduce the need for oxygen therapy among the most ill COVID-19 patients, according to the results of a small clinical trial. Read more
-
UK to test mixed vaccine doses
More than 800 people in the UK will take part in the world’s first trial of mixing the two major kinds of COVID-19 vaccine in a £7 million study, it was announced today. Read more
-
12 week vaccine booster delay unexpectedly effective
The British government gambled correctly when it decided to extend the interval for booster vaccine doses to 12 weeks, according to a significant new analysis. Read more